Related by context. Frequent words. (Click for all words.) 59 metastatic hormone refractory 57 IIa clinical trial 56 phase IIa 54 Phase Ib clinical 54 Phase 2a trial 54 pertuzumab 54 Anthim 54 Phase 2a clinical 53 Diamyd ® 53 double blinded placebo 53 multiple ascending dose 53 SRT# [003] 53 BNC# 53 Nimotuzumab 53 Pivotal Trial 52 GVAX 52 tanespimycin 52 ozarelix 52 phase 2a 52 Allovectin 7 R 52 axitinib 52 Phase 2b study 52 Cloretazine R VNP#M 52 Phase Ia 52 Phase IIb clinical 51 Phase 1a 51 inhibited tumor 51 active comparator 51 Phase IIa clinical 50 randomized Phase III 50 Telcyta 50 Secondary endpoints include 50 dose escalation trial 50 TOCOSOL Paclitaxel 50 Phase 1b clinical 50 Asentar 50 phase IIb 50 MIRCERA 49 multicenter clinical 49 Phase IIa trial 49 Phase 2b 49 tezampanel 49 valopicitabine 49 ocrelizumab 48 TELCYTA 48 temsirolimus 48 placebo controlled clinical 48 Reolysin 48 8 CYL 48 Mylotarg 47 Xyotax 47 NSABP 47 ICA # 47 Phase 2a 47 Secondary endpoints included 47 abiraterone 47 randomized controlled clinical 47 Phase IIb 46 Phase 1b trial 46 6 CYL 46 Phase 2b trial 46 PRX # 46 confirmatory Phase III 46 VentrAssist 46 Phase Ib 46 efficacy 46 Gabapentin GR 46 blinded placebo controlled 46 commercialization milestones 46 placebo controlled randomized 46 tolerated dose MTD 46 marketable securities totaled 45 NexACT 45 Phase IIa clinical trials 45 clinical trials 45 SPIRIT III 45 Phase III clinical 45 Jordan Yerman 45 #.#μm [001] 45 Phase II 45 Phase III pivotal 45 ProLindac 45 dose escalation study 44 confirmatory Phase 3 44 dose cohorts 44 multicenter randomized double 44 multicenter randomized 44 Phase IIb trial 44 ataluren 43 Phase IIa 43 RECIST criteria 43 dose escalation 43 clinical trial 43 Phase III clinical trials 43 tamoxifen therapy 43 multicentre 43 Phase III 43 Phase III randomized 43 pharmacokinetic studies 43 Probuphine 43 placebo controlled trials